CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in IMVT — Immunovant, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in IMVT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$26,223,209
+$9,817,930 QoQ
Shares Held
680,592
+3.1% QoQ
Ownership
0.330%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 226 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IMVT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. IMVT ranks #57 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in IMVT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,223,209 | 680,592 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $16,405,279 | 660,438 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $16,344,399 | 642,974 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $9,360,819 | 580,696 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $10,578,336 | 661,146 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $10,708,799 | 626,612 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $13,981,228 | 564,442 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $15,749,779 | 552,430 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $12,174,914 | 461,171 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $14,283,734 | 442,084 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $18,414,180 | 437,080 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $14,866,143 | 387,240 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $7,856,311 | 414,144 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $6,025,123 | 388,467 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $6,863,108 | 386,654 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,701,760 | 304,975 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,190,014 | 305,132 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,642,613 | 298,115 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,478,740 | 290,932 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,340,894 | 269,378 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $3,534,988 | 334,436 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $5,317,051 | 331,487 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $14,031,321 | 303,774 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $8,747,987 | 248,593 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $3,791,368 | 155,703 | Shares | Sole | 2020-08-20 | |
| No filing history on record for this holder in this stock. | ||||||